Team Private Equity
IGS GeboJagema designs, manufactures and services complex, high-precision moulds used to produce medical devices such as drug-delivery systems, contact lenses and diagnostic equipment. Its technology helps pharmaceutical and healthcare companies manufacture critical products accurately, consistently and at scale.
Rabo Private Equity supported IGS GeboJagema’s international growth alongside management and Smile Invest, including its expansion in the United States. This helped strengthen the company’s capabilities and international presence, enabling it to serve healthcare and pharmaceutical customers across a broader range of markets.
“It has been a privilege to support IGS over the past years and invest alongside management and Smile Invest. We’re proud to have contributed to their impressive growth journey, and, with BC Partners now joining, we’re confident IGS is in excellent hands for the future.”
